BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 4 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Recs

0
Player Avatar portico2011 (59.22) Submitted: 9/21/2013 9:35:26 PM : Outperform Start Price: $76.75 BMRN Score: -28.88

Buyout candidate

Featured Broker Partners


Advertisement